| comparative in situ hybridisation study of juvenile laryngeal papillomatosis in papua new guinea and australia. | a comparative study of cases of juvenile laryngeal papillomatosis from papua new guinea (n = 3) and brisbane, australia (n = 9) was carried out. in situ hybridisation reactions for human papillomavirus (hpv) types 6 and 11 occurred in 11 cases. all three cases from papua new guinea and eight from australia gave positive signals. a negative reaction was observed in one australian case. the intensity of the reaction was strong in seven cases, moderate in one, and weak in three. an equivocal reacti ... | 1990 | 2176227 |
| relation between hla antigens and skin cancer in renal transplant recipients in queensland, australia. | on the basis of previous studies that showed a negative association between hla-a11 and skin cancer in renal transplant recipients and a positive association with hla-b27 and hla-dr7, we performed a study in queensland with 1098 recipients to address the question of whether the same associations could be found. the influence of hla mismatching and hla homozygosity on the risk of skin cancer was also studied. in contrast to earlier studies, hla-a11 was associated with an increased risk of skin ca ... | 1997 | 9129219 |
| case-control study in a subtropical australian population to assess the relation between non-melanoma skin cancer and epidermodysplasia verruciformis human papillomavirus dna in plucked eyebrow hairs. the nambour skin cancer prevention study group. | epidermodysplasia verruciformis human papillomavirus (ev-hpv) dna has been demonstrated in malignant and benign skin lesions and in hairs plucked from renal transplant recipients and immunocompetent patients. we investigated the association between ev-hpv dna in hairs plucked from eyebrows and the occurrence of non-melanoma skin cancer (nmsc) in a community-based study. within a cohort of residents of a queensland township (nambour), nested case-control studies of recently developed nmsc (64 cas ... | 2000 | 10728604 |
| benchmarking epidemiological characteristics of cervical cancer in advance of change in screening practice and commencement of vaccination. | to investigate trends in cervical cancer incidence, mortality and survival by histology for benchmarking purposes ahead of practice change and the introduction of human papilloma virus (hpv) vaccine. | 2007 | 17461006 |
| school-based vaccinations delivered by general practice in rural north queensland: an evaluation of a new human papilloma virus vaccination program. | a local general practice was contracted to provide the school-based immunisation program over two years in mount isa, queensland. the schedule was for female year 10, 11 and 12 students to receive three doses of human papilloma virus (hpv) vaccination (gardasil). this was provided as part of the broader immunisation program that involved providing year 8 students with two doses of hepatitis b vaccination and one dose of varicella-zoster, and year 10 students with one dose of diphtheria-tetanus-p ... | 2008 | 18522312 |
| marrying research, clinical practice and cervical screening in australian aboriginal women in western new south wales, australia. | research shows that australian aboriginal women experience a significantly higher rate of mortality from cervical cancer than non-aboriginal women. we now understand that infection with human papillomavirus (hpv) is a necessary pre-requisite for cervical cancer. this knowledge, together with the development of prophylactic vaccines against the hpv types most commonly associated with cervical cancer (16 and 18), made it vital to gain nationally representative hpv genotyping data for australian wo ... | 2009 | 19459723 |
| a review of histological outcomes from peri-menopausal and post-menopausal women with a cytological report of possible high grade abnormality: an alternative management strategy for these women. | to investigate the histological outcomes of women with cytological reports of possible high grade abnormality and to determine if patient age may be a clinically significant factor in determining the presence of high grade disease for this cytological category. | 2010 | 20025476 |
| catching up with the catch-up: hpv vaccination coverage data for australian women aged 18-26 years from the national hpv vaccination program register. | this report describes human papillomavirus (hpv) vaccine coverage data for australian women 18-26 years of age, as notified to the national human papillomavirus vaccination program register. a cross-sectional analysis was conducted of notifications to the register of hpv vaccine doses delivered as part of the national hpv vaccination program, which provided free catch-up vaccination to women 18-26 years of age across australia between 2007 and 2009. hpv vaccination coverage estimates were calcul ... | 2011 | 22010515 |
| low prevalence of human papillomavirus in oral cavity squamous cell carcinoma in queensland, australia. | while human papillomavirus (hpv) is an accepted risk factor for oropharyngeal squamous cell carcinoma (scc), its aetiological role in oral cavity scc remains unclear. this study aimed to determine the hpv prevalence in an australian population. | 2016 | 27091484 |
| human papillomavirus status and p16(ink4a) expression in patients with mucosal squamous cell carcinoma of the head and neck in queensland, australia. | the last decade has seen changes in the epidemiology of mucosal squamous cell carcinomas of the head and neck (hnsccs), with increasing numbers of cases attributable to human papillomavirus (hpv) infection. we sought to determine the prevalence of hpv and p16(ink4a) expression in australian hnscc patients and to identify predictors of hpv-positivity. | 2015 | 25677091 |
| effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case-control study nested within a population based screening programme in australia. | to measure the effectiveness of the quadrivalent human papillomavirus (hpv) vaccine against cervical abnormalities four years after implementation of a nationally funded vaccination programme in queensland, australia. | 2014 | 24594809 |
| comparison of oropharyngeal and oral cavity squamous cell cancer incidence and trends in new zealand and queensland, australia. | increases in the incidence of squamous cell oropharyngeal cancer (opc) have been reported from some countries, but have not been assessed in australia or new zealand. this study examines trends for squamous cell opc and squamous cell oral cavity cancer (occ) in two similarly sized populations, new zealand and queensland, australia. | 2014 | 24445141 |
| squamous cell carcinoma of the vulva: a comparison between women 35 years or younger and 90 years or older. | this study aimed to compare clinical features, diagnosis, management, and outcomes between women 35 years or younger and 90 years or older with vulvar squamous cell carcinoma referred to queensland centre for gynaecological cancer between 1983 and 2010. | 2013 | 23733164 |
| immunisation coverage annual report, 2011. | this, the 5th annual immunisation coverage report, documents trends during 2011 for a range of standard measures derived from australian childhood immunisation register data, and national human papillomavirus (hpv) vaccination program register data. the proportion of children 'fully vaccinated' at 12, 24 and 60 months of age was 91.4%, 92.2% and 89.5% respectively. although pneumococcal vaccine had similar coverage at 12 months to other vaccines, coverage was lower for rotavirus at 12 months (83 ... | 2013 | 24882234 |
| cervical cancer in women under 25 years of age in queensland, australia: to what extent is the diagnosis made by screening cytology? | the current australian national cervical screening program (ncsp) involves biennial, cytology-based screening of women from the age of 18 years. from december, 2017 this will change to a five-yearly human papilloma virus-based screening commencing at age 25. there is some concern that the new program may delay the opportunistic detection of cervical cancers in women under 25 years. | 2017 | 28580578 |